FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:2657-2665 December 27, 2007 Number 26 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set CME Exam Supplementary Material Editorial by Estes, N.A. M. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background For patients who have a ventricular tachyarrhythmic event, implantable cardioverter–defibrillators (ICDs) are a mainstay of therapy to prevent sudden death. However, ICD shocks are painful, can result in clinical depression, and do not offer complete protection against death from arrhythmia. We designed this randomized trial to examine whether prophylactic radiofrequency catheter ablation of arrhythmogenic ventricular tissue would reduce the incidence of ICD therapy.

Methods Eligible patients with a history of a myocardial infarction underwent defibrillator implantation for spontaneous ventricular tachycardia or fibrillation. The patients did not receive antiarrhythmic drugs. Patients were randomly assigned to defibrillator implantation alone or defibrillator implantation with adjunctive catheter ablation (64 patients in each group). Ablation was performed with the use of a substrate-based approach in which the myocardial scar is mapped and ablated while the heart remains predominantly in sinus rhythm. The primary end point was survival free from any appropriate ICD therapy.

Results The mortality rate 30 days after ablation was zero, and there were no significant changes in ventricular function or functional class during the mean (±SD) follow-up period of 22.5±5.5 months. Twenty-one patients assigned to defibrillator implantation alone (33%) and eight patients assigned to defibrillator implantation plus ablation (12%) received appropriate ICD therapy (antitachycardia pacing or shocks) (hazard ratio in the ablation group, 0.35; 95% confidence interval, 0.15 to 0.78, P=0.007). Among these patients, 20 in the control group (31%) and 6 in the ablation group (9%) received shocks (P=0.003). Mortality was not increased in the group assigned to ablation as compared with the control group (9% vs. 17%, P=0.29).

Conclusions In this randomized trial, prophylactic substrate-based catheter ablation reduced the incidence of ICD therapy in patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden death. (Current Controlled Trials number, ISRCTN62488166 [controlled-trials.com] .)

Source Information

From the Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston (V.Y.R., K.J., J.N.R.); the Harvard–Thorndike Electrophysiology Institute and Arrhythmia Service, Beth Israel Deaconess Medical Center, Boston (M.R.R., A.W.R., M.E.J.); and the Cardiac Arrhythmia Service, Homolka Hospital, Prague, Czech Republic (P.N., M.T., S.K., L.S.).

Address reprint requests to Dr. Josephson at the Cardiovascular Division, Harvard–Thorndike Electrophysiology Institute and Arrhythmia Service, Beth Israel Deaconess Medical Center, 185 Pilgrim Rd., Boston, MA 02215, or at mjoseph2{at}bidmc.harvard.edu.

Full Text of this Article

Related Letters:

Catheter Ablation in Patients with ICDs
Kanagaratnam P., Koa-Wing M., Peters N. S., Coceani M.
Extract | Full Text | PDF  
N Engl J Med 2008; 358:2295-2296, May 22, 2008. Correspondence

This article has been cited by other articles:

• Duray, G. Z., Schmitt, J., Richter, S., Israel, C. W., Hohnloser, S. H. (2009). Arrhythmic death in implantable cardioverter defibrillator patients: a long-term study over a 10 year implantation period. Europace 11: 1462-1468 [Abstract] [Full Text]  
• Shivkumar, K., Tung, R. (2009). Improving our understanding of epicardial ventricular tachycardia in nonischemic cardiomyopathy.. J Am Coll Cardiol 54: 809-811 [Full Text]  
• Sivagangabalan, G., Pouliopoulos, J., Huang, K., Barry, M. A., Lu, J., Thomas, S. P., Ross, D. L., Thiagalingam, A., Kovoor, P. (2009). Simultaneous Biventricular Noncontact Mapping and Ablation of Septal Ventricular Tachycardia in a Chronic Ovine Infarct Model. Circ Arrhythm Electrophysiol 2: 441-449 [Abstract] [Full Text]  
• Mont, L., Guasch, E., Berruezo, A. (2009). An implantable defibrillator and what else?. Eur Heart J 30: 1551-1553 [Full Text]  
• Aliot, E. M., Stevenson, W. G., Almendral-Garrote, J. M., Bogun, F., Calkins, C. H., Delacretaz, E., Bella, P. D., Hindricks, G., Jais, P., Josephson, M. E., Kautzner, J., Kay, G. N., Kuck, K.-H., Lerman, B. B., Marchlinski, F., Reddy, V., Schalij, M.-J., Schilling, R., Soejima, K., Wilber, D. (2009). EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Europace 11: 771-817 [Full Text]  
• Tops, L. F., Bax, J. J. (2009). The Year in Imaging Related to Electrophysiology. J Am Coll Cardiol Img 2: 498-510 [Full Text]  
• Koplan, B. A., Stevenson, W. G. (2009). Ventricular Tachycardia and Sudden Cardiac Death. Mayo Clin Proc. 84: 289-297 [Abstract] [Full Text]  
• Protas, L., Dun, W., Jia, Z., Lu, J., Bucchi, A., Kumari, S., Chen, M., Cohen, I. S., Rosen, M. R., Entcheva, E., Robinson, R. B. (2009). Expression of skeletal but not cardiac Na+ channel isoform preserves normal conduction in a depolarized cardiac syncytium. Cardiovasc Res 81: 528-535 [Abstract] [Full Text]  
• Lau, D. H., Clausen, C., Sosunov, E. A., Shlapakova, I. N., Anyukhovsky, E. P., Danilo, P. Jr, Rosen, T. S., Kelly, C., Duffy, H. S., Szabolcs, M. J., Chen, M., Robinson, R. B., Lu, J., Kumari, S., Cohen, I. S., Rosen, M. R. (2009). Epicardial Border Zone Overexpression of Skeletal Muscle Sodium Channel SkM1 Normalizes Activation, Preserves Conduction, and Suppresses Ventricular Arrhythmia: An In Silico, In Vivo, In Vitro Study. Circulation 119: 19-27 [Abstract] [Full Text]  
• Sivagangabalan, G., Pouliopoulos, J., Huang, K., Lu, J., Barry, M. A., Thiagalingam, A., Ross, D. L., Thomas, S. P., Kovoor, P. (2008). Comparison of Electroanatomic Contact and Noncontact Mapping of Ventricular Scar in a Postinfarct Ovine Model With Intramural Needle Electrode Recording and Histological Validation. Circ Arrhythm Electrophysiol 1: 363-369 [Abstract] [Full Text]  
• Knackstedt, C., Schauerte, P., Kirchhof, P. (2008). Electro-anatomic mapping systems in arrhythmias. Europace 10: iii28-iii34 [Abstract] [Full Text]  
• Sacher, F., Tedrow, U. B., Field, M. E., Raymond, J.-M., Koplan, B. A., Epstein, L. M., Stevenson, W. G. (2008). Ventricular Tachycardia Ablation: Evolution of Patients and Procedures Over 8 Years. Circ Arrhythm Electrophysiol 1: 153-161 [Abstract] [Full Text]  
• Kanagaratnam, P., Koa-Wing, M., Peters, N. S., Coceani, M. (2008). Catheter Ablation in Patients with ICDs. NEJM 358: 2295-2296 [Full Text]  
• Wellens, H. J. (2008). Forty Years of Invasive Clinical Electrophysiology: 1967-2007. Circ Arrhythm Electrophysiol 1: 49-53 [Full Text]  
• Estes, N.A. M. III (2007). Ablation after ICD Implantation -- Bridging the Gap between Promise and Practice. NEJM 357: 2717-2719 [Full Text]  
• (2007). SMASHing Ventricular Tachyarrhythmias: Can Ablation Prevent Implantable Cardioverter-Defibrillator Events?. Journal Watch Cardiology 2007: 1-1 [Full Text]